Courage Capital Management’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-375
Closed -$130K 16
2018
Q4
$130K Sell
375
-375
-50% -$291K 0.1% 17
2018
Q3
$870K Sell
750
-465
-38% -$428K 0.47% 17
2018
Q2
$1.04M Buy
1,215
+253
+26% +$210K 0.78% 14
2018
Q1
$1.13M Sell
962
-38
-4% -$42K 0.86% 17
2017
Q4
$924K Hold
1,000
0.66% 12
2017
Q3
$1.1M Hold
1,000
0.73% 12
2017
Q2
$1.15M Buy
1,000
+375
+60% +$456K 0.59% 12
2017
Q1
$721K Buy
625
+125
+25% +$121K 0.59% 11
2016
Q4
$527K Hold
500
0.33% 14
2016
Q3
$200K Buy
+500
New +$204K 0.08% 15

Other funds holding HSTO

Courage Capital Management's HSTO Position: Q1 2019 in Review

Courage Capital Management sold out of Histogen Inc. Common Stock (HSTO) in Q1 2019, closing a stake of 375 shares — an estimated $130K sold.

Courage Capital Management first reported a position in HSTO in Q3 2016 and held it in 10 quarters. The position peaked at $1.15M in Q2 2017. 42 funds tracked by Wall St. Rank hold HSTO as of Q1 2019.

  • Courage Capital Management reported no remaining Histogen Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Courage Capital Management sold 375 Histogen Inc. Common Stock shares in Q1 2019, an estimated $130K.
  • Courage Capital Management first reported a position in Histogen Inc. Common Stock in Q3 2016 and held it in 10 quarters.
  • Courage Capital Management's Histogen Inc. Common Stock position peaked at $1.15M in Q2 2017.
  • 42 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q1 2019.

Based on Courage Capital Management's 13F filing for Q1 2019, filed 14 May 2019.